A National Measles Surveillance Strategy
DOI:
https://doi.org/10.33321/cdi.1999.23.3Keywords:
measles control, measles surveillance, guidelinesAbstract
This surveillance plan has been formulated to help prepare for national measles elimination. It updates and expands upon the surveillance methodology previously outlined in Measles: Guidelines for the control of outbreaks in Australia which was developed by the National Health and Medical Research Council (NHMRC).
Downloads
References
National Health and Medical Research Council. Measles: Guidelines for the control of outbreaks in Australia, 1996.
National Health and Medical Research Council. The Australian immunisation handbook: Chapter 3.4 - Measles Mumps Rubella. 1997; Sixth Edition: 82-96.
Expanded Programme on Immunisation. Using surveillance data and outbreak investigations to strengthen measles immunization programmes. 1996; 96.02: 1-24.
Murray CJL, Lopez AD. Evidence-based health policy - lessons from the Global Burden of Disease Study. Science 1996;274: 740-743.
National Advisory Committee on Immunisation (NACI). Supplementary statement on measles elimination in Canada. Canada Communicable Diseases Report 1996;22:9-15.
Anonymous. Measles eradication: recommendations from a meeting cosponsored by the World Health Organization, The Pan American Health Organization, and the Centers for Disease Control. MMWR 1997;46: 1-20.
Measles - United States, 1996, and the interruption of indigenous transmission. MMWR 1997;46: 242-246.
Accelerated surveillance and control of measles in the Western Pacific Region. 1996; WPR/VID/EPI (2)96.8: 1-13.
Ferson MF, Young LC, Robertson PW, Whybin LR. Difficulties in clinical diagnosis of measles: proposal for a modified clinical case definition. Med J Aust 1995;163: 364-366.
Gay N, Ramsay M, Hesketh L, Morgan-Capner P, Brown D, Miller E. The epidemiology of measles in England and Wales since the 1994 vaccination campaign. Communicable Disease Report 1997;7: R17-21.
Benenson AS, Chin J. Measles. In: Control of Communicable Diseases Manual, 16th ed. Washington: American Public Health Association, 1995: 293-298.
Vitek CR, Redd SC, Redd SB, Hadler SC. Trends in importation of measles to the United States, 1986-94. JAMA 1997;277: 1952-1956.
Anonymous. Measles - United States, 1997. MMWR 1998;47: 273-276.
Centers for Disease Control and Prevention. Chapter 6: Measles. In: Manual for the surveillance of vaccine-preventable diseases. Centers for Disease Control and Prevention, Atlanta, GA, 1996.
Mayo DR, Brennan T, Cormier DP, Hadler J, Lamb P. Evaluation of a commercial measles virus immunoglobulin M enzyme immunoassay. J Clin Microbiol 1991;29:2865-2867.
Helfand RF, Heath JL, Anderson LJ, Maes RF, Guris D, Bellini WB. Diagnosis of measles with an IgM capture EIA: the optimal timing of specimen collection after rash onset. Journal of Infectious Diseases 1997; 175: 195-199.
Erdman D, Anderson L, Adams D, Stewart J, Markowitz L, Bellini W. Evaluation of monoclonal-based capture immunoassay for detection of specific antibodies to measles virus. J Clin Microbiol 1991;29: 1466-1471.
Hummel K, Erdman D, Heath B, Bellini W. Baculovirus expression of the nucleoprotein gene of measles virus and utility of the recombinant protein in diagnostic enzyme immunoassays. J Clin Microbiol 1992;30:2874-2880.
Griffin D, Bellini W. Measles virus. In: Fields BN, Knipe DM, Howley PM, eds. Fields Virology, 3rd ed. Philadelphia: Lippincott-Raven, 1996.
Chen RT, Markowitz L, Albrecht P, et al. Measles antibody: reevaluation of protective titres. J Infect Dis 1990;162:1036-1042.
Anonymous. Measles prevention. MMWR 1989;Suppl9:38:1-18:1-18.
Duncan R. The use of ELISA for rapid diagnosis: antibody detection. In: Kemeny D, Challacombe S, eds. ELISA and other solid phase immunoassays, Wiley and Sons, 1998.
Mori T. A simple method for genetic differentiation of the AIK-C vaccine strain from wild strains of measles virus. Biologicals 1994;22:179-185.
Rota JS, Heath JL, Rota PA, et al. Molecular epidemiology of measles virus: identification of pathways of transmission and implications for measles elimination. Journal of Infectious Diseases 1996;173: 32-37.
Anonymous. Progress towards global measles control and elimination, 1990-1996. MMWR 1997;46: 893-897.
Ruckle G, Rogers K. Studies with measles virus: II: isolation of virus and immunological studies in persons who have had the natural disease. J Immunol 1957; 78: 341-355.
Gresser I, Katz SL. Isolation of measles virus from urine. N Engl J Med 1960;275: 516-523.
Brown DW, Ramsay ME, Richards AF, Miller E. Salivary diagnosis of measles: a study of notified cases in the United Kingdom, 1991-3. BMJ 1994;308: 1015-1017.
Cutts FT, Bartoloni A, Guglielmetti P, Brown D, Bianchi Bandinelli ML, Roselli M. Prevalence of measles antibody among children under 15 years of age in Santa Cruz, Bolivia: implications for vaccination strategies. Transactions of the Royal Society of Tropical Medicine and Hygiene 1995; 89: 119-122.
Gustsafon TL, Lievens AW, Brunell PA, et al. Measles outbreak in a fully immunised secondary-school population. N Engl J Med 1987; 316: 771-774.
McDonnell LF, Jorm LR, Patel MS. Measles outbreak in western Sydney. Vaccine failure or failure to vaccinate? Med J Aust 1995;162: 471-475.
Babad HR, Nokes DJ, Gay NJ, Miller E, Morgan-Capner P, Anderson RM. Predicting the impact of measles vaccination in England and Wales: model validation and analysis of policy options [published erratum appears in Epidemiol Infect 1995 Aug;115(1):213]. Epidemiology and Infection 1995;114:319-344.
Gay NJ, Hesketh LM, Morgan-Capner P, Miller E. Interpretation of serological surveillance data for measles using mathematical models: implications for vaccine strategy. Epidemiology and Infection 1995;115:139-156.
Morgan-Capner P, Wright J, Miller CL, Miller E. Surveillance of antibody to measles, mumps, and rubella by age. BMJ 1988;297:770-772.
Gay NJ, Miller E. Was a measles epidemic imminent? Communicable Disease Report CDR Review. 1995;5:R204-207.
Ramsay M, Gay N, Miller E, et al. The epidemiology of measles in England and Wales: rationale for the 1994 national vaccination campaign. Communicable Disease Report CDR Review 1994;4:R141-146.
Tobias M, Mansoor O. Predicting the next measles epidemic. NZ Public Health Rep 1997;4: 1-3.
Anonymous. Update: vaccine side effects, adverse reactions, contraindications, and precautions. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1996;45:1-35.
Salisbury DM, Campbell H, Edwards B. Measles Rubella Campaign in England. One year on. Health Promotion Division and Measles Control Agency, Department of Health, November 1995.
Orenstein WA, Bernier RH, Hinman AR. Assessing vaccine efficacy in the field. Further observations. Epidemiol Rev 1988;10: 212-241.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 1999 Communicable Diseases Intelligence
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
